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Abstract: Schistosomiasis, caused by helminth flatworms of the genus Schistosoma, is an infectious
disease mainly associated with poverty that affects millions of people worldwide. Since treatment
for this disease relies only on the use of praziquantel, there is an urgent need to identify new
antischistosomal drugs. Piplartine is an amide alkaloid found in several Piper species (Piperaceae)
that exhibits antischistosomal properties. The aim of this study was to evaluate the structure–function
relationship between piplartine and its five synthetic analogues (19A, 1G, 1M, 14B and 6B) against
Schistosoma mansoni adult worms, as well as its cytotoxicity to mammalian cells using murine fibroblast
(NIH-3T3) and BALB/cN macrophage (J774A.1) cell lines. In addition, density functional theory
calculations and in silico analysis were used to predict physicochemical and toxicity parameters.
Bioassays revealed that piplartine is active against S. mansoni at low concentrations (5–10 µM),
but its analogues did not. In contrast, based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) and flow cytometry assays, piplartine exhibited toxicity in mammalian cells at
785 µM, while its analogues 19A and 6B did not reduce cell viability at the same concentrations.
Int. J. Mol. Sci. 2018, 19, 1802; doi:10.3390/ijms19061802 www.mdpi.com/journal/ijms
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This study demonstrated that piplartine analogues showed less activity against S. mansoni but
presented lower toxicity than piplartine.
Keywords: piplartine; analogues; Schistosoma mansoni; cytotoxicity
1. Introduction
Schistosomiasis, caused by helminth flatworms of the genus Schistosoma, is a chronic and often
painful disease mainly associated with poverty that affects more than 200 million people worldwide,
resulting in major economic and personal impacts from the years of healthy life lost to morbidity [1].
Recent global burden of disease estimates indicate that approximately 10,000 schistosomiasis-related
deaths occur each year [2]. Moreover, the current estimate of yearly disability adjusted life-years
(DALYs) for schistosomiasis is 3.4 million [3]. Three species (Schistosoma mansoni, Schistosoma
haematobium and Schistosoma japonicum) account for the majority of human infections. The major
aetiological agent of human schistosomiasis is S. mansoni and intestinal schistosomiasis caused by this
species is present in Africa, the Middle East, the Caribbean, and South America [4].
Human treatment with praziquantel is playing a central role in the control and prevention of
schistosomiasis, being the only effective drug currently available [5]. However, praziquantel does not
prevent re-infection and its continued extensive use may result in the future emergence of drug-resistant
parasites. Having a single drug to treat a disease that affects millions of people is a real concern and,
consequently, it is imperative to develop new effective antischistosomal drugs [6].
The use of natural products has a long tradition in medicine, and they have proven to be an
important source of lead compounds in the development of new drugs. In order to provide new
compounds for use in drug development to control schistosomiasis, the search for anthelmintic
compounds, mainly from natural sources, has intensified in recent years [7–11]. Indeed, as reviewed
elsewhere, natural compounds have been recognized as promising candidates for antischistosomal
drugs [12].
In the north-eastern region of Brazil, several plants with active metabolites have been discovered,
among them is the Piperaceae family, which includes several compounds with antimicrobial
activities [13]. Piplartine (3,4,5-trimethoxycinnamoyl-N-dihydropyridin-2-one), also known as
piperlongumine were described in several species of Piper genus, and anti-inflammatory, antitumor,
antifungal, and antiparasitic effects were reported (for review see [14]). Our group previously
demonstrated that piplartine at 10 µM possesses in vitro schistosomicidal activity against S. mansoni
schistosomula and adult worms [15,16]. We also showed that piplartine caused morphological alterations
in the tegument of parasites in a concentration-dependent manner. The antischistosomal effect of piplartine
in association with other molecules (e.g., praziquantel) had also been described [17,18].
The activity of a molecule is characterised not only by its biological activity against
microorganisms, but also by its toxicity in various mammalian cells. Toxicity studies are, therefore,
performed prior to the administration of a molecule to humans. In order to establish a relationship
between the chemical structure of piplartine and its biological effects, in this study new analogues
of piplartine were synthesised and evaluated against adult S. mansoni ex vivo. The cytotoxicity of
compounds was also evaluated on murine fibroblast (NIH-3T3) and BALB/cN macrophage (J774A.1)
cell lines. Additionally, we also performed theoretical calculations and ultraviolet–visible absorption
spectra to characterize the obtained compounds. Furthermore, physicochemical and toxicological
parameters of piplartine and its derivatives were obtained by a computer-aided prediction.
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2. Results
2.1. Theoretical Calculations and Ultraviolet–Visible Absorption Spectra
The electron density data for the tested molecules are shown in Figure 1, and indicate that
piplartine had the highest dipole moment (5.47). Regions coloured red tended to have a more negative
charge, being polar, while those in blue were more positive. Figure 2 represents the ultraviolet–visible
(UV–Vis) light absorption spectrum of piplartine and its analogues, showing maximum absorbance
from 280 to 400 nm, with dislocation at the bands of the analogues in relation to the original molecule.
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Figure 1. Electron density: (a) piplartine; (b) 19A; (c) 1G; (d) 14B; (e) 6B and (f) 1M. The colours
represent negative (red) and positive (blue). The dipole moments of all compounds in debye values are as
follows: piplartine: 5.4728337; 1G: 1.9658996; 1M: 4.4568136; 6B: 4.0062111; 14B: 3.9403826; 19A: 3.7385640.
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Figure 2. Ultraviolet and visible light absorption spectra of piplartine and its analogues in arbitrary
units (A.U.).
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2.2. In Silico Studies Information
To investigate the differences between piplartine and its analogues, a structural and
physicochemical analysis was performed to calculate the van der Waals surface area (vdW), molecular
electrostatic potential (MEP) surface, molecular lipophilicity potential (MLP) and polar surface area
(PSA), LogP values, predicted solubility, and molecular weight of the compounds, using the ChemAxon
method. The results are shown in Table 1. Despite significant differences in surface area, the most
significant difference between the compounds was in the topological polarised surface area (TPSA).
TPSA of a molecule was defined as the surface sum over all polar atoms and is based simply on the
summation of polar fragments representing tabulated surface contributions, i.e., bonding patterns of a
molecule [19]. The fragments present in the molecules were compared with a library of substructure
fragments to determine the toxic characteristics of each of the studied molecules as well as to predict
toxicity activity. The results of this analysis are shown in Table 2, and indicate that piplartine shows
greater toxicity and increased ability to bind to nuclear receptors than its analogues, effects that can be
related to its cytotoxic effects observed during in vitro tests in mammalian cells. In addition, the Ames
mutagenicity prediction revealed only positive for piplartine.
Table 1. Basic, geometric, structural, and solubility parameters of the parent and analogue compounds.
Compounds Piplartine 19A 14B 6B 1M 1G
Basic properties
Atom count 40 51 31 48 56 38
Mw 315.32 287.31 432.48 387.39 239.27 359.42
Structural properties
Asymmetric atom count 0 0 0 0 0 0
Rotatable bond count 5 6 2 5 7 5
Ring count 2 2 3 3 3 2
Aromatic ring count 2 1 2 3 3 2
Hetero ring count 1 1 2 0 0 1
Hydrogen bond donor count 0 0 0 3 1 0
Hydrogen bond acceptor count 5 5 2 5 5 4
Formal charge 0 0 0 0 0 0
Fsp3 (a) 0.18 0.40 0.13 0.00 0.12 0.19
Topological polar surface area (A2) 65.07 65.07 31.23 93.11 77.10 49.69
Molar refractivity cm3/mol 87.42 101.15 70.63 112.82 123.64 79.89
Polarisability (A3) 32.54 38.29 26.66 41.46 46.66 30.59
Solubility parameters
logP 1.89 2.71 2.36 3.55 4.63 2.26
Milogp(b) 2.19 2.78 4.69 5.02 2.86 2.90
logD pH range 1.7–8.0 1.89 2.71 2.36 3.54 4.63 2.26
Intrinsic solubility −3.01 −4.53 −2.87 −4.73 −5.48 −2.81
Solubility category High Moderate High Low Low High
logS pH range 1.7–8.0 −3.01 −4.53 −2.87 −4.73 −5.48 −2.81
Geometry parameters
Van der Waals volume (Å3) 281.06 337.61 213.99 341.62 390.54 260.80
Volume (Å3) (b) 282.84 263.86 394.07 340.76 218.97 339.43
Van der Waals surface area (Å2) 425.62 543.27 333.75 515.78 620.14 423.69
Solvent accessible surface area (Å2) 549.15 659.24 445.82 631.17 725.57 577.96
Topological polar surface area (Å2) 65.07 65.07 31.2 93.11 77.10 49.69
Absorbance 322 nm 329 nm 321 nm 312 nm 306.5 nm 301.5 nm
(a) Number of sp3 carbons/number of carbons; (b) Molinspiration method. 19A, 14B, 6B, 1M, and 1G are analogue
compounds of piplartine. Fraction of sp3 carbon atoms (Fsp3).
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Table 2. Toxicity analysis and bioactivity prediction of the parent and analogue compounds against
various drug targets.
Compounds Piplartine 19A 14B 6B 1M 1G
Toxicity prediction (c)
AMES toxicity Yes No No No No
Max. tolerated dose (human) (0.505 log mg/kg/day) 1.006 0.677 1.043 1.095 1.051 1.114
hERG I inhibitor No No No No No
hERG II inhibitor No No No Yes No
Oral Rat Acute Toxicity (LD50) (2.661 mol/kg) 2.268 2.295 2.413 2.195 2.37 2.389
Oral Rat Chronic Toxicity (LOAEL) (3.402 log mg/kg bw/day) 1.64 1.787 1.812 2.455 2.388 1.592
Hepatotoxicity No Yes No Yes Yes No
Skin sensitisation No No No No No No
T. pyriformis toxicity(0.285 × log µg/L) 1.138 1.359 2.004 0.437 0.658 1.591
Minnow toxicity (5.577 × log mM) 1.293 0.446 1.179 −0.172 −0.914 1.027
Predictive bioactivity (b)
GPCR ligand 0.13 0.17 0.07 −0.11 −0.04 −0.15
Ion channel modulator −0.51 −0.16 −0.53 −0.27 −0.29 −0.54
Kinase inhibitor −0.13 −0.12 −0.13 −0.20 −0.09 −0.14
Nuclear receptor ligand −0.32 −0.07 −0.12 −0.31 −0.31
Protease inhibitor −0.40 0.02 −0.39 −0.38 −0.33 −0.48
Enzyme inhibitor −0.02 0.05 0.24 −0.17 −0.12 −0.00
(a) Number of sp3 carbons/number of carbons; (b) Molinspiration method; (c) pkCSM. The Ames test is
a widely employed method that uses bacteria to test whether a given chemical can cause mutations in the
DNA of the test organism (Ames); The human ether-a-go-go-related gene (hERG); median lethal dose (LD50);
Lowest-Observed-Adverse-Effect Level (LOAEL); G-protein-coupled receptors (GPCR).
2.3. Cytotoxicity Assay
The cytotoxicity of piplartine and its analogues was evaluated by MTT assay in a murine fibroblast
(NIH-3T3) cell line at concentrations from 25 to 800 µg/mL. The results demonstrated that piplartine
decreased cell viability after 24 h of exposure, exhibiting considerable toxicity (Figure 3). Analogues 1G,
14B, and 1M promoted a considerable reduction in cell viability at concentrations of 400 and 800 µg/mL
when compared with piplartine. Furthermore, 1G and 14B presented the highest pD2 and Emax values
when compared with the other analogues (Table 3). However, analogues 19A and 6B did not exert
significant effects on mammalian cell viability at the tested concentrations when compared with the
effects of piplartine (Figure 3). The pD2 values of 19A and 6B were estimated based on their respective
Emax values, which were lower than 50% (Table 3), indicating lower cytotoxicity than piplartine and
the other analogues. Thus, among the tested compounds, piplartine presented the highest toxicity.
The dimethylsulphoxide (DMSO) vehicle control displayed no effect on cell viability.
Table 3. Determination of pD2 and Emax for the cytotoxic effect of piplartine and its analogues in
murine fibroblast (NIH-3T3) cells.
Compounds pD2 (−logIC50) a Emax (%) b
19A −3.06 ± 0.15 37.93 ± 2.85
1G −2.00 ± 0.03 95.69 ± 0.79
1M −2.31 ± 0.04 70.94 ± 1.20
14B −1.95 ± 0.04 83.64 ± 0.47
6B −2.80 ± 0.08 47.93 ± 2.52
Piplartine 5.68 ± 2.95 96.94 ± 0.12
a Negative logarithm of the mean inhibitory concentration (IC50); b Emax: decrease in cell viability at the maximum
concentration tested (800 µg/mL).
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Figure 3. Cytotoxicity evaluation using the MTT method in murine fibroblast (NIH3T3) cells after
exposure for 24 h to piplartine analogues (A) 19A (72–2331 µM), (B) 6B (62–1998 µM), (C) 1G
(85–2738 µM), (D) 1M (56–1796 µM), (E) 14B (101–3250 µM) and (F) piplartine (78–2514 µM). Molecules
were used at the same concentrations range at µg/mL for all samples (25–800). Dimethyl sulfoxide
(DMSO) was used as a negative control. The values are expressed as mean ± SEM. * p < 0.05 vs.
DMSO control group. The dotted lines mark the 100% viability level.
The cytotoxicity of piplartine and its analogues was also evaluated by flow cytometry in a mouse
BALB/cN macrophage (J774A.1) cell line at concentrations of 25, 100 and 400 µg/mL with exposure
for 24 h (Figure 4). The DMSO vehicle control caused a significant (p < 0.05) reduction in cell viability,
similar to the hydrogen peroxide (H2O2) cell death control. Piplartine significantly (p < 0.05) affected
cell viability at concentrations of 25 and 100 µg/mL when compared with a DMEM untreated control.
Analogue 1M, at all tested concentrations, and analogue 1G at 100 µg/mL (342 µM) significantly
altered (p < 0.05) cell viability in comparison with the negative control, but not in a toxic manner.
Other analogues did not show significant effects on cell viability. Interestingly, treatment with
piplartine and its analogues appeared to reduce the cytotoxicity of the DMSO vehicle on J774A.1 cells.
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Figure 4. Cytotoxicity evaluation in the mouse BALB/cN macrophage (J774A.1) cell line following
exposure for 24 h to piplartine analogues (A) 19A (72, 291 and 1165 µM), (B) 6B (62, 249 and 999 µM),
(C) 1G (85, 342 and 1369 µM), (D) 1M (56, 224 and 898 µM), (E) 14B (101, 406 and 1625 µM) and (F)
piplartine (78, 314 and 1257 µM). Molecules were used at the same concentrations range at µg/mL for
all samples (25, 100 and 400). Dulbecco’s Modified Eagle Medium (DMEM) was used as a negative
control. Cells were analysed by flow cytometry (20,000 events/sample). The values are expressed as
mean ± SEM. * p < 0.05 and **** p < 0.0001 vs. DMEM control group.
In the same cell viability assay, the percent of non-viable cells was analysed regarding the cytotoxic
mechanism in mammalian cells using annexin-V conjugated to green-fluorescent FITC and propidium
iodide (PI) staining to distinguish apoptotic cells (annexin-V FITC) from necrotic cells (PI) by flow
cytometry (Figure 5 and Figure S2). As expected, the control of cell death by apoptosis (H2O2)
showed a significant (p < 0.05) increase in annexin-V FITC fluorescence intensity compared with the
DMEM negative control. A significant (p < 0.05) increase in annexin-V FITC staining was observed in
J774A.1 cells following treatment with piplartine 25 µg/mL (785 µM) and analogue 14B at 400 µg/mL
(1625 µM) when compared with the DMEM negative control. Furthermore, significant (p < 0.05)
differences between the annexin-V FITC and PI fluorescent signals were observed for each group of
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J774A.1 cells treated with piplartine and its analogues, indicating that apoptosis was the principal
mechanism of cell death.
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Figure 5. Evaluation of the cell death mechanism mediated by (A) piplartine (78, 314 and 1257 µM) and
its analogues (B) 1G (85, 342 and 1369 µM), (C) 1M (56, 224 and 898 µM), (D) 6B (62, 249 and 999 µM),
(E) 14B (101, 406 and 1625 µM) and (F) 19A (72, 291 and 1165 µM) in J774A.1 cells following treatment
for 24 h at the same concentrations range at µg/mL for all samples (25, 100 and 400) using annexin-V
FITC (apoptosis marker) and propidium iodide (PI, necrosis marker) staining. Cells were analysed
by flow cytometry (20,000 events/sample). The values are expressed as mean ± SEM. * p < 0.05 vs.
DMEM untreated control group. # p < 0.05 vs. apoptosis staining from each respective group.
2.4. In Vitro Experiments in Adult Worms of S. mansoni
The activity of the amide piplartine and its analogues against adult worms of S. mansoni aged
49 days was most prominent at the concentration of 10 µM and incubation time of 96 h (Table 4).
The amide piplartine showed activity against the parasite 24 h after incubation, while its analogues
showed no activity at the tested concentrations when compared with piplartine, as noted in Table S1.
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Table 4. In vitro effects of compounds in 49-day-old S. mansoni worms.
Group Period of Incubation
(h)
Dead Worms (%) a
Motor Activity Reduction (%) a
Slight Significant
M F M F M F
Control b
24 0 0 0 0 0 0
48 0 0 0 0 0 0
72 0 0 0 0 0 0
96 0 0 0 0 0 0
0.5% DMSO
24 0 0 0 0 0 0
48 0 0 0 0 0 0
72 0 0 0 0 0 0
96 0 0 0 0 0 0
Praziquantel 24 100 100 0 0 100 100
2 µM
48 100 100 0 0 100 100
72 100 100 0 0 100 100
96 100 100 0 0 100 100
Amide piplartine 24 100 100 0 0 100 100
10 µM 48 100 100 0 0 100 100
5 µM
72 100 100 0 0 100 100
96 100 100 0 0 100 100
24 0 0 100 100 0 0
48 0 0 100 100 0 0
72 0 0 100 100 0 0
96 60 60 0 0 60 60
a Percentages relative to the 20 worms investigated; b RPMI 1640. The effect of the compounds on motor activity of
adult S. mansoni was assessed qualitatively. Male (M) and Female (F).
3. Discussion
Schistosomiasis is a global public health problem, and the search is ongoing for drugs to treat this
neglected disease and meet the requirements of the standard treatment, praziquantel. Because it is a
safe medication when administered to children, adults, the elderly and pregnant women, with low
toxicity and few side effects, the use of praziquantel has been increasing, despite the number of
patients who are resistant to the drug. Thus, the development of new anthelmintic compounds to treat
schistosomiasis has become a major research objective [6,20].
Natural products represent an alternative to conventional therapeutic compounds because of
the diversity in molecules and biological activities that these products present. Biodiversity results
a large number of compounds with activities that are as yet unknown. Despite advancements in
biotechnology, genomics and medicinal chemistry, the discovery of new drugs for the treatment of
schistosomiasis remains challenging, since in addition to biological activity, drugs are required to
have low toxicity [6,21]. In this context, the objective of this work was to study the schistosomicidal
activity and cytotoxicity of piplartine and its synthetic analogues, and to compare the analogues to the
parent compound.
An alternative strategy to minimise drug resistance is the chemical synthesis of established drugs
or natural compounds with activities previously described in the literature, where chemical-structural
modifications are made in functional groups that may be responsible for biological activity [6].
These modifications can increase, decrease or abolish biological activity; in some instances,
these changes can promote decreased toxicity, but with an associated loss of biological activity.
The structural changes made to piplartine to produce the analogues in this study resulted in a loss of
activity against S. mansoni and a decrease in toxicity. Studies show that phenotypic analysis remains the
optimal approach to the screening of anthelmintics as it is a simple and low-cost, qualitative strategy,
widely used in in vitro testing [22,23].
Several studies have demonstrated the activity of a range of natural products against S. mansoni,
although the mechanism of action of these compounds remains unknown, such as, piplartine, which is
highly active against this parasite [15]. Previous results have shown that piplartine promotes changes
in motility, instigating the death of the parasite, and that no difference in response was observed
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between male and female parasites [15]. According to the theoretical data shown in Figure 1, piplartine
presents a higher electron density around the molecule, with a dipole moment of 5.47, which may
influence its anthelmintic activity.
It is necessary for a drug to go to the market that the drug has good ADMET (absorption,
distribution, metabolism, excretion, toxicity) properties. Drug toxicology is one of the crucial research
fields in the preclinical study. Toxicity is a leading cause of attrition at all stages of drug development.
In silico prediction of compound toxicity which can reduce the expenses of the company and save a lot
of time has attracted considerable attention [24].
Compound 1G did not exhibit antischistosome activity at the concentrations tested. As shown
in Figure 1, this compound had a low electron density, presenting a very low dipole moment
when compared with piplartine. Changes in the functional groups of a molecule can influence
its biological activity, and in this compound, modifications were observed in the dihydropiperidinone
ring, which was replaced by piperidinyl [25].
Compounds 14B and 19A have similar electron densities, based on their dipole moment values,
which are close to that of piplartine. The 19A molecule has a double bond between the rings
that underwent modifications, as well as a change in the aliphatic chain between these two rings.
Compound 14B underwent a dihydropiperidinone modification, being replaced with a piperidinyl
ring, and in the trimethoxybenzene moiety, substitution with a benzodioxol ring quashed the
schistosomicidal activity of this derivative [25]. These compounds have high electron densities and are
highly similar to piplartine but are large and bulky compounds when compared with their prototype.
These features may explain their lack of interaction with enzymes and ion channel receptors in the
parasite, promoting the loss of biological activity against S. mansoni when compared with piplartine,
whereas piplartine at low concentrations promotes alteration of the parasite tegument. Compound 14B
has a double bond between the two altered portions, thus increasing the distance between the two rings
forming the compound, which may have influenced the loss of this biological activity.
Compounds 1M and 6B present electronic densities similar to piplartine, according to Figure 1,
but did not present biological activity against the S. mansoni parasite. This loss in activity may be
related to the large size of these molecules, which prevents binding to enzymes that are in the tegument,
meaning that these molecules are unable to promote the necessary modifications in the membrane of the
parasite tegument leading to the death of the parasite. In the compound 1M, the dihydropiperidinone
moiety has been replaced by a trimethoxybenzene ring and the trimethoxybenzene moiety has been
replaced by a dicyclohexyl ring. This change in the position of the trimethoxybenzene ring may
influence the biological response by causing this compound to lose its activity against the parasite.
In compound 6B, the trimethoxybenzene is replaced by a dicyclohexyl ring, as in compound 1M,
which may promote the loss of activity against S. mansoni parasite when compared with piplartine,
because both of these compounds, with this same alteration, lost biological activity.
Complementary studies are still required to determine the relationship between the chemical
structure and biological activities of piplartine and its analogues to facilitate the discovery of
new prototypes from piplartine. The substitution of a hydrogen atom with a different functional
group such as methoxyl, nitro, halogen or others may alter the biological activity, and this may
subsequently promote changes in the duration and nature of the pharmacological effect as well
as in the physicochemical characteristics of the molecules, thus contributing to the production of
new molecules. From this study, it can be observed that functional groups trimethoxybenzene and
dihydropiperidinone are important for promoting schistosomicidal activity, because their removal or
alteration in modified analogues resulted in the loss of biological activity as well as the toxicity of the
compound [26].
In murine fibroblast cells, piplartine showed toxicity at all concentrations tested while compounds
1G and 14B, but not the other derivatives, showed toxicity at 200, 400 and 800 µg/mL. As shown by
the solubility parameters (Table 1), ultraviolet and visible light absorption spectra of piplartine and
its analogues it was possible to observe that the analogues present values close to that of piplartine,
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indicating that there are similarities of functional groups between these molecules (Table 1 and
Figure 2),; these compounds presented values close to that of piplartine, and the toxicity analysis
and bioactivity prediction (Table 2) showed that these synthetic compounds were again similar to
piplartine, thus explaining their toxicity. Similarly, flow cytometry cytotoxicity assays in mouse
BALB/cN macrophages showed that piplartine was more toxic to mammalian cells than the analogues.
However, a marked reduction in the cytotoxicity mediated the by DMSO vehicle was observed in cells
treated with piplartine and the analogues, indicating not only that the molecules modulated the toxic
effect in mammalian cells but also that they had a protective effect.
Annexin-V FITC/PI staining was used to determine the cell death mechanism observed in the
cytotoxicity assays by flow citometry. Recombinant annexin-V conjugated to FITC identifies exposed
phosphatidylserine on the inner membrane and is used to detect the initial phase of apoptosis [27],
while PI, a red-fluorescent nucleic acid probe to which living cells are impermeable, can be used to
detect necrotic cells [28]. In this study, piplartine- and analogue-treated J774A.1 cells showed increased
annexin-V FITC staining after 24 h compared to that after PI staining, suggesting that the mechanism
of cell death was related to apoptosis [29]. Apoptosis is characterized by cell shrinkage, chromatin
condensation and systematic DNA cleavage in a controlled way which prevents the inflammatory
process [30]. These data indicate the potential of a rational design of bioactive molecules with low
toxicity from piplartine, while further studies are required.
Studies show that the biological and toxicological activity of piplartine can be attributed to
the presence of the α, β unsaturated carbonyl groups, where the substitution of any of these
unsaturated groups leads a molecule without cytotoxicity and to the loss of biological activity [14,31,32].
Research using this compound has indicated that the α, β unsaturated groups in the aliphatic chain
present between the two rings are important for the biological activity against S. mansoni as they
maintain the conformational arrangement of the two rings, whereas changes in this arrangement
decrease cytotoxicity. This effect was observed in the compounds synthesised without the double bond.
This study shows that the modification of piplartine to produce its derivatives resulted in
the loss of schistosomicidal activity, indicating that the functional groups trimethoxybenzene
and dihydropiperidinone are essential. The synthesis approach used promoted alterations in
conformational arrangements, the hydrophilic-lipophilic balance, and the distribution of electronic
density compared to those of piplartine. Modifications to trimethoxybenzene and the aliphatic chain
were the most significant, as changes to the methoxyl radical in the meta position of the aromatic ring
promoted the loss of schistosomicidal activity and subsequent reduction in toxicity.
4. Materials and Methods
4.1. Piplartine and Synthetic Analogues
Roots of Piper tuberculatum were harvested on the campus of the University of São Paulo (USP),
São Paulo, Brazil. Botanical classification was performed by Elsie Franklin Guimarães (Instituto de
Pesquisas Jardim Botânico do Rio de Janeiro). A voucher specimen (Kato-0169) has been deposited
at the herbarium of the same institute. Piplartine was isolated from the dry roots of P. tuberculatum
according to a published procedure [25]. Purity was determined by reversed-phase chromatography
(RP-HPLC) and the structure by proton nuclear magnetic resonance (1H-NMR) as described also in
the supplemental material section (Figure S1).
The cinnamides 1G and 14B were synthesised by adding triethylamine (3 equivalent) and amine
(pyrrolidine) to a solution of acid chloride (1 equiv) in CH2Cl2. To prepare the acid chloride, a solution
of 3,4,5-trimethoxycinnamic acid and 3,4-methylenedioxy cinnamic acid (1 equiv.) (Sigma Aldrich,
St. Louis, MO, USA) in dry tetrahydrofuran (THF) (10 mL), kept under nitrogen atmosphere,
and oxalyl chloride (5 equiv.) was added dropwise and stirred at room temperature for 5–6 h.
Excess oxalyl chloride was then removed under reduced pressure, yielding the corresponding acid
chloride. The reaction mixture was stirred overnight at room temperature, and quenched with
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saturated aqueous NH4Cl, and extracted with CH2Cl2 (three times). The combined organic phases
were washed with brine and dried over MgSO4. After filtration and concentration, the residue was
purified by flash chromatography to provide the desired amide [33].
Compounds 1M and 6B were synthesised by adding to a solution of 2E-3,4,5-trimethoxycinnamic
acid and 4-nitrocinnamic acid (1 equiv.) in THF 0.9 equiv. of N,N′-dicyclohexylcarbodiimide
(DCC). The reaction mixture was stirred overnight at room temperature and dried on a rotary
evaporator to remove any remaining solvent. The product was dissolved in (dichloromethane) DCM,
a saturated solution of NaHCO3 was added, and the resulting solution was washed three times
with DCM. The organic phase was combined, dried with MgSO4, filtered, and concentrated under
pressure. The obtained crystalline product was then recrystallised on hot methanol or purified by
chromatography [25,33].
Compound 19A was obtained by adding to a solution of acid chloride (1 equiv.) in THF 1 equiv.
butanol. The 2E,4E-5-3,4,5-trimethoxyphenyl penta-2,4-dienoic acid was synthetised as described
previously [34].
4.2. Theoretical Calculations
Density Functional Theory (DFT) [35] calculations were performed to determine the energy of the
frontier orbitals with b3lyp [36] and basis set 6-311g with two polarisation functions (d,p) and diffuse
functions for hydrogen (++), using Gaussian 09 software (Gaussian Inc., Wallingford, CT, USA) for
theoretical calculations [37]. Dipole moment structures were calculated to determine electron density
using GaussView 5.0 software (Gaussian Inc., Wallingford, CT, USA).
4.3. UV–Vis Absorption Spectra
Ultraviolet and visible light (UV–Vis) absorption spectra of piplartine and its analogues were
obtained with a UV-1280 spectrophotometer (Shimadzu, Kyoto, Japan). Purified piplartine and
its analogues (1G, 1M, 6B and 14B) were solubilised in HPLC-grade acetonitrile and diluted to a
concentration of 15 µg/mL. Because of its high absorbance and low solubility, the 19A analogue was
further diluted to 7.5 µg/mL before measurement. Scans were performed using a quartz cuvette
with a path length of 1 cm in the 200–450 nm range against a baseline recorded with acetonitrile at
room temperature.
4.4. In Silico Physicochemical and Toxicity Studies
Two-dimensional structures were designed using Marvin Sketch 17.4.3, 2017, ChemAxon
(Available online: http://www.chemaxon.com). 3D structures were geometrically optimised
using Another Molecular Modeling Program—Vis (AMMP-Vis) (AMMP 2.0, Monterey, CA,
USA), a full-featured molecular dynamics program for manipulating both small molecules and
macromolecules including proteins, nucleic acids, and other polymers [38]. Ammp-Mon charges were
added and an assisted model building with energy refinement (AMBER) field force was applied to
minimise the energy conformation using a genetic algorithm with 3000 steps, applying the water
dielectric constant. The conformational search was performed using the Boltzmann jump method,
with flexible and psi torsions, at 300 K, and with dielectric constant equal to 80,000 and root mean
squared deviation RMSD equal to 60.00.
Physicochemical properties were also calculated, including molecular weight (MW), lipophilicity
(logP), octanol-water coefficient solubility (logD), water solubility (logS), rotatable bonds, topological
polar surface area (tPSA), number of hydrogen bond acceptors and number of hydrogen bond donors
using Chemicalize, a web tool to predict basic, geometric, structural and solubility parameters,
Calculation, August/2017, (Available online: https://chemicalize.com/; developed by ChemAxon
(Available online: http://www.chemaxon.com)).
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The toxicity analyses were performed by pkCSM [39,40]. The biological activity of the parent
drug and related compounds was predicted using the Molinspiration web server (http://www.
molinspiration.com/).
4.5. Cytotoxicity Assay
4.5.1. NIH3T3 and J774A.1 Cell Culture
Murine fibroblast (NIH3T3) cells were acquired from the cell bank of Rio de Janeiro (Rio de Janeiro,
Brazil), and the murine BALB/cN macrophage (J774A.1, TIB-67™) (ATCC®, Washington, DC, USA).
Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco BRL, Grand Island, NY,
USA) supplemented with 10% heat inactivated foetal bovine serum (Life, USA) and 1% antibiotic
solution (100 IU/mL penicillin/100 µg/mL streptomycin, Life, USA) at 37 ◦C and 5% CO2.
4.5.2. Cell Viability Assays
Viability assays were performed by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) dye reduction method. NIH3T3 cells were seeded into 96-well culture plates at a density
of 3 × 103 cells in DMEM culture medium overnight at 37 ◦C and 5% CO2 in a humid atmosphere.
Next, the medium was removed and various concentrations (25–800 µg/mL) of samples reconstituted
in 3% DMSO were applied. DMSO (3%) was used as a control. The plates were incubated for
24 h [28]. Next, 15 µL of MTT solution (5 mg/mL in phosphate buffer) was added to each well and
the plates were incubated for 2 h. Medium was discarded and 100 µL of DMSO was added to each
well. Absorbance was determined using a spectrophotometer with a microplate reader at 595 nm
(Molecular Devices Corporation, Sunnyvale, CA, USA).
For viability assays by flow cytometry method, J774A.1 cells were seeded into 96-well culture
plates at a density of 1.0 × 105 cells in DMEM culture medium for 2 h at 37 ◦C and 5% CO2 in a
humid atmosphere, and samples reconstituted in 1% DMSO were added to final concentrations of 25,
100 and 400 µg/mL. The plates were incubated for 24 h [28], washed in phosphate buffered saline,
and resuspended in 100 µL of binding buffer (10 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid) HEPES buffer pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2). Cells were then treated with 2 µL
of annexin-V FITC (Apoptosis Detection Kit; BD Biosciences, Franklin Lakes, NJ, USA) and 2 µL of
propidium iodide (PI, 50 µg/mL) for 15 min in the dark at room temperature. Next, 100 µL binding
buffer was added and samples were analysed by flow cytometry (BD LSFortessaTM, Franklin Lakes,
NJ, USA). A total of 20,000 events were collected per sample.
4.6. Animals and Parasites
The Belo Horizonte (BH) strain of S. mansoni was maintained in Biomphalaria glabrata snails
and Mesocricetus auratus hamsters at the Adolfo Lutz Institute (São Paulo, Brazil) according to
standard procedures. Detailed methods for the infection of molluscs and hamsters, as well as for
the recovery of parasites, were as described previously [41]. Briefly, the intermediate host snails
were exposed to light for approximately 3 h and cercariae of S. mansoni were subsequently harvested.
Hamsters (aged 3 weeks, weight 25 g) were infected subcutaneously with 150 cercariae and, 49 days
post-infection, adult S. mansoni specimens were recovered from each hamster by perfusion with
Roswell Park Memorial Institute (RPMI) medium 1640 medium (Invitrogen, São Paulo, Brazil) and
heparin. This study was approved by the Institutional Review Board of the Guarulhos University
(São Paulo, Brazil; approval number 31/17, 20 March 2017). All animals were handled in strict
accordance with good animal practice as defined by the Animal Use Ethics Committee.
4.7. Adult Schistosomes
The preparations and culture of schistosomes was performed as previously described [42,43].
Briefly, hamsters were killed 49 days after infection for the recovery of adult schistosomes. Next, fresh
Int. J. Mol. Sci. 2018, 19, 1802 14 of 17
adult worm pairs (male and female) were washed and placed in a 24-well culture plate (TPP, St. Louis,
MO, USA) containing RPMI 1640 medium supplemented with 10% foetal bovine serum (Gibco-BRL,
Life Technologies do Brazil Ltda, Sao Paulo, SP, Brazil), 200 µg/mL streptomycin, and 200 IU/mL
penicillin (Invitrogen, São Paulo, SP, Brazil) at 37 ◦C in a 5% CO2 atmosphere. Adult schistosomes
were maintained continuously in medium (with or without drugs) for 96 h as described below.
4.8. In Vitro Experiments with Adult Worms of S. mansoni
In vitro assays in S. mansoni adults were performed with mated males and females. The worm
pairs obtained from the infusion hamsters were washed twice with RPMI 1640 medium containing
200 U/mL penicillin, 200 µg/mL streptomycin and 2 µg/mL amphotericin B (Vitrocell, Campinas,
Brazil). The mated parasites were then transferred into 24-well cell culture plates (TPP, St. Louis,
MO, USA) containing, per well, 1 pair of worms in 2 mL of RPMI 1640 medium supplemented with
10% foetal bovine serum and buffered with 25 mM HEPES. Worms were incubated with the amide
pyramethrin analyzes at different concentrations (50, 25, 10 and 5 µM); 5 and 10 µM piplartine for up
to 96 h; 2 µM praziquantel was used as positive control and culture medium was used as a negative
control [44].
Cultures of adult worms were monitored by microscopy or magnifying glass. The effect of the
drug was assessed with emphasis on changes in worm motor activity and death of worms as previously
described [45–47]. The mortality of worms was judged by the absence of movement for 2 min or when
touched with forceps.
4.9. Statistical Analysis
Statistical analysis was performed by analysis of variance (ANOVA) and Bonferroni post hoc
test using Graph Pad Prism 5.03 (GraphPad Software, La Jolla, CA, USA) to evaluate the statistical
significance of differences between control and treated cells in cytotoxicity assays. All values were
expressed as means ± standard error of the mean (SEM) from triplicates in three independent
experiments, and a value of p < 0.05 was considered statistically significant.
5. Conclusions
This study demonstrated that analogues of piplartine, when compared with the parent molecule,
showed a loss of activity against the S. mansoni parasite, but showed decreased toxicity compared to
that of piplartine. Alterations in the trimethoxybenzene ring of piplartine, following unsaturation of the
aliphatic chain and the dihydropiperidinone ring, were shown to be highly sensitive to modification,
promoting the loss of biological activity and decreased toxicity. These findings indicate that analogous
molecules within the same series do not present the same physicochemical and biological activity.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/6/
1802/s1.
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